放化联合治疗老年非小细胞肺癌的可行性

 目的　评价老年非小细胞肺癌的单纯放疗及放疗化疗综合治疗的疗效及毒副作用 ,探讨其治疗可行性。方法　 89例老年中晚期非小细胞肺癌患者 ,其中单纯放疗组 4 3例 ,放疗 +化疗综合治疗组 4 6例 ,比较两组的疗效和毒副作用。结果　单纯放疗组和放化综合治疗组的局部有效率、1年及 2年生存率分别为 6 9.77%、4 1 .86 %、1 7.1 4 %和 76 .0 9%、4 7.83%、2 1 .2 1 % ,经统计学处理 ,P >0 .0 5。两组毒副作用有显著的差异 ,综合治疗组胃肠道反应、骨髓抑制均比单放组明显。结论　老年中晚期非小细胞肺癌治疗十分复杂 ,应根据患者个体情况来选择治疗方案

The analysis of treatment with radiothyropy and chemothyropy to old patients with Non-small cell lung cancer

Objective To evaluate the treatment and side effect of pure radiothyropy and radiothyropy combined chemothyropy to eld patients with non small cell lung cancer (NSCLC) and the possibilities of the treatment of radiothyropy combined with chemothyropy. Methods 89 cases with NSCLC were analysed retrospectively and 43 cases among them were treated with pure radiotherapy, 46 cases with radiotherapy and chemothyrapy. The effect and side effect were compared between them, respectively. Results The local utility rates were 69.77% in pure group and 76.09% in union group ( P > 0.05 ). The annual survival rates were 41.86% and 47.83% , two years survival rates were 17.14% and 21.21% , respectively( P > 0.05 ). The side effect including gastrointestinal response and bone marrow depression in union treatment group was marked higher than that in solo group. ( P < 0.05 ). Conclusion The method taken to cure the patients with NSCLC should be chosen according to the detailed state of patients.